Patients with chronic hepatitis D infection do not benefit substantially from lamivudine

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1507, 2005-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lamivudine is effective in paediatric patients with chronic hepatitis B virus (HBV) infection

Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

A Preliminary Benefit-Risk Assessment of Lamivudine for the Treatment of Chronic Hepatitis B Virus Infection

By Zoulim F.

Drug Safety, Vol. 25, Iss. 7, 2002-01 ,pp. : 497-510

Adis International

Access to resources Recommend Favorite

Lamivudine for chronic hepatitis B - dosage in paediatric patients

Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Lamivudine: In Children and Adolescents with Chronic Hepatitis B Virus Infection

By Keam S.J. Scott L.J.

Pediatric Drugs, Vol. 4, Iss. 10, 2002-01 ,pp. : 687-694

Adis International

Access to resources Recommend Favorite

One Year of Lamivudine Therapy for Portuguese Patients with Chronic Hepatitis B

By Areias J.

Clinical Drug Investigation, Vol. 23, Iss. 5, 2003-01 ,pp. : 339-346

Adis International

Access to resources Recommend Favorite